Annual Cash & Cash Equivalents
$5.75 M
-$22.62 M-79.72%
31 December 2023
Summary:
Annovis Bio annual cash & cash equivalents is currently $5.75 million, with the most recent change of -$22.62 million (-79.72%) on 31 December 2023. During the last 3 years, it has fallen by -$2.32 million (-28.73%). ANVS annual cash & cash equivalents is now -87.40% below its all-time high of $45.69 million, reached on 31 December 2021.ANVS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$12.64 M
+$8.64 M+216.09%
30 September 2024
Summary:
Annovis Bio quarterly cash and cash equivalents is currently $12.64 million, with the most recent change of +$8.64 million (+216.09%) on 30 September 2024. Over the past year, it has increased by +$6.28 million (+98.85%). ANVS quarterly cash and cash equivalents is now -74.33% below its all-time high of $49.22 million, reached on 30 June 2021.ANVS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANVS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.7% | +98.8% |
| 3 y3 years | -28.7% | -73.4% |
| 5 y5 years | +10000.0% | +10000.0% |
ANVS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.4% | at low | -73.4% | +302.8% |
| 5 y | 5 years | -87.4% | >+9999.0% | -74.3% | >+9999.0% |
| alltime | all time | -87.4% | >+9999.0% | -74.3% | >+9999.0% |
Annovis Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.64 M(+216.1%) |
| June 2024 | - | $4.00 M(+27.4%) |
| Mar 2024 | - | $3.14 M(-45.5%) |
| Dec 2023 | $5.75 M(-79.7%) | $5.75 M(-9.4%) |
| Sept 2023 | - | $6.35 M(-59.6%) |
| June 2023 | - | $15.72 M(-6.2%) |
| Mar 2023 | - | $16.76 M(-40.9%) |
| Dec 2022 | $28.38 M(-37.9%) | $28.38 M(-11.3%) |
| Sept 2022 | - | $31.99 M(-11.1%) |
| June 2022 | - | $35.97 M(-15.7%) |
| Mar 2022 | - | $42.67 M(-6.6%) |
| Dec 2021 | $45.69 M | $45.69 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $47.46 M(-3.6%) |
| June 2021 | - | $49.22 M(+778.6%) |
| Mar 2021 | - | $5.60 M(-30.6%) |
| Dec 2020 | $8.07 M(>+9900.0%) | $8.07 M(-8.7%) |
| Sept 2020 | - | $8.84 M(-9.5%) |
| June 2020 | - | $9.76 M(-12.2%) |
| Mar 2020 | - | $11.12 M(>+9900.0%) |
| Dec 2019 | $1900.00(-94.6%) | $1900.00(-96.6%) |
| Sept 2019 | - | $56.30 K(-46.2%) |
| June 2019 | - | $104.60 K(-68.9%) |
| Mar 2019 | - | $336.60 K(+853.5%) |
| Dec 2018 | $35.30 K(-89.8%) | $35.30 K |
| Dec 2017 | $347.50 K | - |
FAQ
- What is Annovis Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Annovis Bio?
- What is Annovis Bio annual cash & cash equivalents year-on-year change?
- What is Annovis Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Annovis Bio?
- What is Annovis Bio quarterly cash and cash equivalents year-on-year change?
What is Annovis Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of ANVS is $5.75 M
What is the all time high annual cash & cash equivalents for Annovis Bio?
Annovis Bio all-time high annual cash & cash equivalents is $45.69 M
What is Annovis Bio annual cash & cash equivalents year-on-year change?
Over the past year, ANVS annual cash & cash equivalents has changed by -$22.62 M (-79.72%)
What is Annovis Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANVS is $12.64 M
What is the all time high quarterly cash and cash equivalents for Annovis Bio?
Annovis Bio all-time high quarterly cash and cash equivalents is $49.22 M
What is Annovis Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, ANVS quarterly cash and cash equivalents has changed by +$6.28 M (+98.85%)